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Cell spreading, proliferation, and survival are modu-
lated by focal adhesions linking extracellular matrix
proteins, integrins, and the cytoskeleton. Zyxin is a
focal-adhesion-associated phosphoprotein with one
domain involved in the control of actin assembly
and three protein±protein adapter domains impli-
cated in the regulation of cell growth and differenti-
ation. We characterized zyxin expression in normal
human melanocytes and six melanoma cell lines in
relation to cell spreading, growth, and differentiation
using Western immunoblotting techniques, image
analysis, ¯ow cytometry, and confocal microscopy.
We found that zyxin, focal adhesion kinase, and pax-
illin were signi®cantly upregulated in melanoma cells
compared to melanocytes. Zyxin expression directly
related to cell spreading and proliferation and inver-
sely related to differentiation, whereas focal adhesion
kinase correlated only to cell spreading and paxillin
did not signi®cantly correlate with any of the param-
eters. Treatment of melanoma cells with 12-O-tetra-
decanoylphorbol-13-acetate downregulated zyxin
expression, inhibited cell spreading and proliferation,
and promoted differentiation. In contrast, 12-O-tet-
radecanoylphorbol-13-acetate, a mitogen for mela-
nocytes, induced upregulation of zyxin expression in
melanocytes. These ®ndings are consistent with a
role of zyxin in modulation of cell spreading, prolif-
eration, and differentiation. Therapies directed at the
downregulation of this focal adhesion phosphopro-
tein in melanoma cells implicate a new approach for
controlling melanoma cell growth. Key words: actins/
cell differentiation/extracellular matrix/focal adhesion kinase/
paxillin/phorbol esters. J Invest Dermatol 118:246±254, 2002
A
dherence of cells to the extracellular matrix (ECM) or
to each other occurs at specialized structures of the
plasma membrane called focal adhesions. These
structures include the adhesion plaques and the zonula
adherens. These membrane sites are important links of
the cell cytoskeleton to the ECM and are associated with signal
transduction pathways that regulate cell proliferation and survival
(Ruoslahti, 1997). The focal adhesion is a macromolecular complex
that, in addition to actin bundles and a5b1 and avb3 integrins,
includes at least 24 structural, regulatory, and signaling proteins (for
reviews see Burridge and Chrzanowska-Wodnicka, 1996;
Schoenwaelder and Burridge, 1999). These include structural actin
associated proteins a-actinin, talin, and vinculin and actin assembly
regulatory proteins pro®lin and vasodilator-stimulated phospho-
protein (VASP). Other molecules that localize to focal adhesions,
including focal adhesion kinase (FAK), paxillin, and the src family
kinases, are also important in signal transduction pathways. The
structural and regulatory complexity of focal adhesions and the
various signaling pathways permit an integrated control of cell
adhesion, proliferation, and differentiation.
One candidate regulatory protein found in focal adhesions is
zyxin, present at relatively low molar ratio in relation to other
structural proteins in the adhesion plaque (Beckerle, 1986). Zyxin is
a phosphoprotein with an apparent molecular weight of 82±84 kDa
(Beckerle, 1986, 1997; Macalma et al, 1996). Zyxin forms speci®c
cross-links with a-actinin (Crawford et al, 1992), cCRP (chicken
cysteine-rich protein) (Sadler et al, 1992), VASP (Reinhard et al,
1995), and the proto-oncogene Vav (Hobert et al, 1996). These
associations place zyxin in position as a candidate regulatory protein
although the details of such mechanisms have yet to be determined.
In addition, zinc-binding sequences known as LIM domains are
found in zyxin (Sadler et al, 1992). These domains act as modular
protein±protein binding interfaces and are found in transcriptional
regulators and proto-oncogene products, raising the possibility that
zyxin could play a key role in mechanical coupling and cell
signaling in the control of cell shape changes and proliferation
(Sadler et al, 1992; Schmeichel and Beckerle, 1994). In support of
such a possible mechanism, zyxin appears to shuttle between the
nucleus and focal adhesions (Nix and Beckerle, 1997). Finally,
zyxin is related to Listeria ActA protein and ectopic zyxin stimulates
actin polymerization (Golsteyn et al, 1997). These ®ndings indicate
an important role of zyxin in the spatial control of actin ®lament
assembly.
In recent years insights have been made into the regulation of
focal adhesions by receptor-mediated signal transduction mechan-
isms. Protein kinase C (PKC) is one of the key proteins in a major
signal transduction pathway that has been implicated in cell
proliferation and motility. PKC is a multifunctional protein serine/
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threonine kinase that plays a central role in intracellular signaling
generated by a variety of cellular effectors through speci®c
individual receptors (Nishizuka, 1995). The details of this regula-
tion impacting on focal adhesions are not fully understood, but it
appears to be mediated through multiple sites including phos-
phorylation of integrins, FAK (Lewis et al, 1996), and regulatory
proteins of acto-myosin contractility (Burridge and Chrzanowska-
Wodnicka, 1996).
Cytokinesis and cell motility require acto-myosin contractility
and phorbol esters such as 12-O-tetradecanoylphorbol-13-acetate
(TPA), a major activator of PKC, has profound effects on cell
proliferation and cell spreading. The cellular response to phorbol
esters is typically cell-type speci®c. Differential responses are
reported in normal compared to malignant cells; for example,
TPA stimulates the proliferation of normal melanocytes, whereas it
inhibits the growth of human melanoma cell lines (Halaban et al,
1986; Becker et al, 1990; Coppock et al, 1992; Arita et al, 1994).
Likewise, TPA induces the expression of several genes in
melanocytes but not their transformed counterpart (Brooks et al,
1992), and evidence suggests the differential TPA-induced effects
are mediated through PKC (Arita et al, 1992; 1994). Although TPA
activates PKC, continued activation over several days leads to
depletion of PKC (Nishizuka, 1989; 1995). The differential
response of melanocytes and melanoma cells to depletion of PKC
indicates differences in the regulatory mechanisms that are respon-
sible for their divergent growth properties and behavior.
Differences in zyxin expression in the focal adhesion may
contribute to altered cell growth and behavior; therefore, we
hypothesize that zyxin expression is differentially expressed in
melanocytes and melanoma cells and that its expression directly
relates to cell spreading, proliferation, and differentiation. We
characterize zyxin expression as well as two other focal adhesion
molecules, FAK and paxillin, in relation to cell proliferation and
cell spreading in melanocytes and six melanoma cell lines by
Western immunoblotting, ¯ow cytometry, and image analysis.
Finally, we examine the effect of TPA-induced depletion of PKC
on the expression and distribution of zyxin in relation to cell
spreading, proliferation, and differentiation using ¯ow cytometry
and confocal laser microscopy.
MATERIALS AND METHODS
Melanocyte and melanoma cell culture Neonatal foreskins from
multiple donors were obtained within 2 h from routine circumcision and
used to culture human melanocytes without phorbol esters as previously
described (Gilchrest et al, 1984; Park et al, 1993) with modi®cations.
Brie¯y, the foreskin was cut into 1 mm strips and incubated for 45 min
at 37°C in 0.25% trypsin. The epidermis was separated from the dermis
after overnight exposure to 0.25% trypsin at 4°C. Primary cultures were
®rst established in medium 199 (Life Technologies, Gaithersburg, MD)
supplemented with 10±9 M triiodothyronine (Collaborative Research
Products, Bedford, MA), 10 mg per ml transferrin (Sigma, St. Louis,
MO), 10 mg per ml insulin (Sigma), 1.4 3 10±6 M hydrocortisone
(Calbiochem, San Diego, CA), 10±9 M choleragen (List Biologicals,
Campbell, CA), 10 ng per ml basic ®broblast growth factor (Amgen,
Thousand Oaks, CA), 10 mg per ml myo-inositol (Sigma), 10 ng per ml
epidermal growth factor (Collaborative Biomedical Products), and 5%
fetal bovine serum (HyClone Laboratories, Logan, UT). To selectively
support melanocyte growth, cells were passaged in the low Ca2+
(0.03 mM) version of this medium (Gilchrest et al, 1984; Naeyaert et al,
1991).
Six different human cutaneous melanoma cell lines used in this study
were previously characterized (Byers et al, 1991). Brie¯y, cell line 6
(PM-WK), a primary melanoma cell line, was isolated from the radial
growth phase of cutaneous malignant melanoma. Cell line 2 (RPM-EP)
and cell line 4 (RPM-MC), two recurrent primary cutaneous mela-
nomas, were obtained from dermal nodules at the primary site and
represent tumorigenic vertical growth phase. Three metastatic cell lines
were derived from either lymph node metastases and included cell lines 1
and 5 (MM-AN and MM-RU), or from a visceral metastasis, cell line 3
(MM-LH). The cells were cultured in minimal essential media with
Eagle's balanced salt solution supplemented with 2% fetal bovine serum,
8% newborn bovine serum, 75 U per ml penicillin, 50 mg per ml
streptomycin, and amphotericin B (Gibco BRL, Gaithersburg, MD). The
cultures were passed at subcon¯uence approximately once a week and
maintained at 37°C in a humidi®ed atmosphere of 5% CO2 and 95% air.
Control experiments included cultivation of melanoma cell lines for 4
and 6 d in melanocyte media.
Immunodetection of zyxin, FAK, and paxillin Western blotting
was performed by modi®cation of the procedures developed by Towbin
et al (1979). Brie¯y, melanocytes and melanoma cells were cultured in
100 mm Petri dishes until they reached subcon¯uence. The dishes were
rinsed three times with ice-cold phosphate-buffered saline (PBS) and
lyzed in lysis buffer containing 20 mM Tris, 2 mM ethylenediamine
tetraacetic acid (EDTA), 0.5 mM ethyleneglycol-bis(b-aminoethyl
ether)-N,N,N¢,N¢-tetraacetic acid (EGTA), 1% Triton X-100, 5 mM
dithiothreitol (DTT), 10 mg per ml aprotinin, 50 nM okadaic acid, and
1 mM phenylmethylsulfonyl ¯uoride (PMSF). Melanoma cell lysates
were centrifuged, pellets were discarded, and protein assay of the
supernatant was performed. Fifty micrograms protein was
electrophoresed in each lane using a 10% sodium dodecyl sulfate (SDS)
polyacrylamide gel. Wet transfer of proteins onto nitrocellulose paper by
electrophoresis was performed in 25 mM Tris, 192 mM glycine, and
20% methanol. After transfer, the upper two-thirds of the nitrocellulose
membranes were blocked in 5% nonfat dry milk in PBS for 1 h at room
temperature with shaking. The lower third of the membranes were
stained with amido black to con®rm equal protein loading. Brie¯y, they
Figure 1. Increased zyxin, FAK, and paxillin expression in
melanoma cells compared to melanocytes. Subcon¯uent melanoma
and melanocyte cultures were harvested as described in Materials and
Methods; 50 mg of total cell protein in 160 ml were loaded into each lane,
electrophoresed, transferred to nitrocellulose membranes and incubated
with the zyxin antibody, and processed by enzyme-linked
chemiluminescence. (A) Top panel, immunoblot for zyxin detection at
84 kDa reveals greater zyxin expression in cell lines 1±6 compared to
melanocytes; bottom panel, bottom portion of the nitrocellulose
membrane with amino black staining shows equal protein loading. (B)
FAK immunoblot at 125 kDa demonstrates increased FAK expression in
melanoma cells compared to melanocytes. (C) Paxillin immunoblot at
65±70 kDa shows increased paxillin expression in melanoma cells
compared to melanocytes.
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were washed in PBS, immersed in amido black [0.5% amido black
(Sigma), 45% methanol, and 9% acetic acid] for less than 1 min and then
destained with 45% methanol, 9% acetic acid, and 46% water for 1 h at
room temperature with agitation. A rabbit polyclonal antizyxin antibody
against human zyxin was kindly provided by M.C. Beckerle (Macalma et
al, 1996). A commercially available af®nity puri®ed goat polyclonal
antibody raised against human zyxin was also used (Santa Cruz
Biotechnology, Santa Cruz, CA; N-19:sc-6438). A mouse anti-FAK
monoclonal antibody (MAB2156) and mouse antipaxillin monoclonal
antibody (MAB3060) were purchased from Chemicon International
(Temecula, CA). The antizyxin rabbit antibody (1:5000), the N-19 goat
antizyxin antibody (1:500), the anti-FAK (1:2500), or the antipaxillin
antibody (1:1000) were diluted in 1% nonfat dry milk in PBS and
incubated with the transferred protein±nitrocellulose membrane at 4°C
overnight. After incubation the membranes were washed in PBS once
for 10 min and then three times in PBS containing 0.05% Tween-20
followed by incubation with the appropriate secondary goat antirabbit
antibody, horse antigoat antibody, or rabbit antimouse antibody (Pierce,
Rockford, IL) in 1% milk for 1 h. Nitrocellulose membranes were
washed again and then incubated for 1 min with the ECL Western
blotting detection reagent (Amersham, Buckinghamshire, U.K.). The
membrane was exposed to pre¯ashed Kodak X-Omat ®lm and
developed after a few seconds to few minutes of exposure.
Image analysis and cell spreading assay Densitometry was performed
on three zyxin as well as FAK and paxillin Western blots using
computerized scanning of the ®lm with a Macintosh scanner and the
IPlab spectrum software (Signal Analytics, Vienna, VA). Each blot was
scanned three times to determine the mean integrated pixel intensity of
the bands. Previous protein loading curves, zyxin immunoblotting, and
blot densitometry reveal a linear relationship of protein loading and gel
densitometry values (Leccia et al, 1999).
Melanocyte and melanoma cell spreading was quanti®ed by computer-
ized planar morphometry as previously described (Byers et al, 1991).
Brie¯y, triplicate cell cultures were placed on the stage of a Nikon
Microphot inverted microscope equipped with a Plexiglas housing,
Nikon incubator, and CO2/air ¯ow mixer to obtain constant pH and
temperature (37°C). Digitized images were taken of three randomly
selected ®elds containing 20±30 cells using the phase contrast 103
objective lens, a Cohu high performance CCD camera (San Diego, CA),
and a power Macintosh 7100/66 with an LG-3 scienti®c frame grabber
card (Scion, Frederick, MD). Mean projected cell area 6 SD was
calculated using image analysis with the IPlab spectrum software
described above. Regression analysis of zyxin densitometry values and
projected cell area was then performed.
To examine the effect of long-term TPA treatment and PKC
depletion (Nishizuka, 1989; 1995) on melanoma cell spreading, mela-
noma cells were detached from subcon¯uent cultures with 0.02% EDTA
(Sigma) and allowed to attach again to 60 mm plastic tissue culture dishes
in serum-containing medium as described above. After 2 h, TPA was
added at different concentrations of 10±7, 10±8, and 10±9 M. After 5 d,
digitized images were taken as described above. Projected cell area of
approximately 60 cells in three ®elds was calculated by image analysis as
described above. Mean projected area 6 SD of the TPA-treated cells
was compared statistically by Student's t test to the control preparations
containing diluent only.
TPA assay on melanoma cell growth and zyxin expression in
melanoma cells and melanocytes Approximately 5 3 104 melanoma
cells from each melanoma cell line, as determined by ¯ow cytometry,
were seeded onto multiple 60 mm Petri dishes. After 3 h incubation at
37°C, TPA (Sigma) or diluent was added to the medium at different
concentrations; 10±7, 10±8, or 10±9 M. After 1, 3, 5, and 7 d, the control
and treated dishes were washed two times with PBS and trypsinized with
0.25% trypsin (Gibco BRL, Grand Island, NY) until all the cells had
detached. Cell growth was determined by ¯ow cytometry. To test the
effect of extended TPA treatment or PKC depletion (Nishizuka, 1989,
1995) on zyxin expression in melanoma cells, 10±7, 10±8, 10±9, 10±10,
and 10±11 M TPA was added to 60 mm Petri dishes previously seeded
with 5 3 104 melanoma cells. After 5 d, the cells were lyzed and
Western immunoblotting was performed as described above. The effect
of TPA on zyxin expression was also tested on normal melanocytes by
Western immunoblotting as described above for melanoma cells.
Immuno¯uorescence of zyxin and actin distribution in melanoma
cells and melanocytes Melanocytes and melanoma cell lines were
cultured in diluent or 10±7 M TPA for 5 d on 10 mg per ml ®bronectin-
coated (Collaborative Research) (Yamada et al, 1990) eight-chamber
Permanox tissue-tek chamber slides (NUNC, Naperville, IL). The
chambers were washed three times with PBS, ®xed for 15 min with
3.7% formaldehyde, 2 mM EGTA, and 2 mM MgCl2, washed with
PBS, and permeabilized for 2 min with 0.2% Triton X-100. After
washing with PBS, 5% goat serum in PBS was added for 30 min to
block nonspeci®c binding sites. For zyxin and actin colocalization, cells
underwent a 1 h incubation with the rabbit polyclonal antihuman zyxin
antibody at a 1:1200 dilution in PBS with 0.5% bovine serum albumin
(BSA). After rinses with PBS, goat antirabbit ¯uorescein isothiocyanate
(FITC; Sigma) was added at a 1:80 dilution in PBS and 0.5% BSA and
incubated for 1 h, washed again with PBS, and incubated with
rhodamine-phalloidin to stain actin ®laments (Molecular Probes, Eugene,
OR) at a 1:40 dilution in PBS and 0.5% BSA. Control preparations
Figure 2. Phase contrast images of
melanocytes and melanoma cells show
characteristic phenotypic differences.
Differentiated melanocyte cultures show bipolar,
tripolar, and polygonal pigmented cells (A). No
contaminating ®broblasts are identi®ed. Melanoma
cells (line 2 shown) (B) exhibit large projected cell
areas compared to melanocytes. Control
melanoma cells treated with melanocyte media for
5 d (C) to 7 d (D) did not exhibit a change in
cell area. Scale bar: 100 mm.
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included the goat antirabbit FITC and the rhodamine-phalloidin without
the antizyxin primary antibody. After washing with PBS, the cells on the
Permanox slides were mounted using the slow-fade kit (Molecular
Probes) followed by cover-slipping. All manipulations were performed at
room temperature. The preparations were examined with a Leica
confocal laser scanning microscope using the 253 (n.a. = 0.75) water
immersion lens. The images were stored on an optical disc, transferred to
the Macintosh computer, and processed using the IPlab spectrum
software described above. Pseudo-color images were generated assigning
the FITC signal green, rhodamine signal red, and the overlap of green
and red signals yellow.
RESULTS
Increased zyxin, FAK, and paxillin expression in melanoma
cells compared to melanocytes In order to examine the
expression of zyxin in human melanoma cells and the biologic
precursor, melanocytes, we used Western blotting analysis of total
cell lysates of these cells. Equal loading of 50 mg soluble protein per
lane from melanocytes and the six melanoma cell lines was
determined spectrophotometrically and con®rmed by amido black
staining of stained nitrocellulose blots. Electrophoresis, transfer of
the separated proteins onto the nitrocellulose membranes,
incubation with the antizyxin antibody, and enzyme-linked
chemiluminescence identi®ed a single band at approximately
84 kDa in each lane (Fig 1A, top panel). This relative mobility
corresponds well with the previously reported molecular weight of
human zyxin (Macalma et al, 1996). Densitometric scanning of the
amido black stained nitrocellulose ®lter (Fig 1A, bottom panel)
con®rmed equivalent protein loading by integrated pixel intensity
of the entire column, although slight differences in amount of
minor protein species were apparent.
Densitometric scanning of three different zyxin blots determined
that zyxin expression in melanocytes was signi®cantly less than for
all the melanoma cell lines tested (p < 0.001). Melanoma cell lines
expressed from two to ®ve times greater zyxin than melanocytes.
Variation in zyxin expression among the melanoma cell lines was
also signi®cant, although less so (p < 0.05), with cell line 2
exhibiting just over twice that expressed in cell line 4.
In order to determine whether other focal adhesion proteins are
upregulated in melanoma cells compared to melanocytes or
whether the upregulation is speci®c to zyxin, we performed
Western immunoblotting for FAK and paxillin. FAK was detected
at the appropriate relative mobility of 125 kDa (Fig 1B) and
paxillin was detected as an appropriate broad band from 65 to
70 kDa (Fig 1C). Both FAK and paxillin were signi®cantly
upregulated in melanoma cells compared to melanocytes; however,
the FAK expression was more similar to the zyxin expression than
the paxillin expression.
Zyxin expression correlates with cell spreading and cell
proliferation To determine if the difference in expression of
zyxin among melanocytes and melanoma cell lines is correlated
with cell spreading and cell proliferation, we investigated the
relationship of the level of zyxin with projected cell area and cell
doubling times. Therefore, to test the ®rst part of this hypothesis,
Figure 3. Zyxin expression correlates with melanocyte and
melanoma cell spreading and growth rates. (A) Computer-assisted
regression analysis of the mean densitometric values of zyxin and the
mean projected cell area was performed for melanocytes and each of the
six melanoma cell lines. Signi®cance p < 0.05 and coef®cient of
correlation 0.91. (B) Regression analysis of zyxin and doubling time (d).
Signi®cance p < 0.05 and coef®cient of correlation 0.93. Squares
represent each melanoma cell line (1±6) or melanocytes (Mc). Zyxin
expression units are mean pixel intensity values.
Figure 4. Increased zyxin localization in
melanoma cells compared to melanocytes.
Double ¯uorescent labeling of melanoma cells
(cell line 2 shown) by direct labeling of actin by
rhodamine-phalloidin (A), indirect labeling of
zyxin (B), and the colocalization of zyxin and
actin (C). Actin bundles are clearly identi®ed that
terminate and overlap (as indicated by the yellow
pseudo-color) with the zyxin-stained oval
adhesion plaque (C). Direct labeling of actin by
rhodamine-phalloidin in melanocytes (D). Focal
adhesions containing zyxin are faint and dot-like
compared to those in melanoma cells (E). Pseudo-
color overlap image shows occasional sites of
zyxin and actin colocalization at the distal
projections (F, arrows). Scale bar: 20 mm.
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digitized phase contrast images of at least 60 cells of melanocytes
and each of the melanoma cell lines were saved in three different
®elds. The phase contrast images of melanocytes (Fig 2A) reveal
smaller projected areas than melanoma cells (Fig 2B). The
projected cell area for each cell was measured with the image
analysis system in triplicate cultures as described in Materials and
Methods. Control experiments with exposure of the melanoma cell
lines to melanocyte media did not signi®cantly change melanoma
projected area after 5 or 7 d (Fig 2C, D, respectively, shown for
cell line 2). Projected cell area, an important parameter of cell
spreading, varied substantially among the melanocytes and the
different cell lines. Melanoma cells were signi®cantly more spread
than melanocytes with two to ®ve times the mean projected area.
Differences among the melanoma cell lines were also present; the
mean area of melanoma cell line 2, for example, was three times
that of cell line 4. Application of regression analysis of all melanoma
cell lines and melanocytes revealed that zyxin expression directly
correlated with the mean cell area with a coef®cient of correlation
(R) of 0.91 and p < 0.05, as illustrated in Fig 3(A).
In order to test the second part of the hypothesis, we compared
the growth rates of all melanoma cell lines and melanocytes with
their respective zyxin expression. Doubling times were obtained
spanning the growth rate in¯ection point from day 3 to day 5 of
day 1, 3, 5, and 7 cell counts as outlined in Materials and Methods.
Neonatal melanocyte doubling time was twice that of the slowest
melanoma cell line. Doubling time and zyxin expression among the
melanocytes and all melanoma cell lines are inversely correlated
with a coef®cient of correlation (R) of 0.93 and p < 0.05, as
illustrated in Fig 3(B). In other words, similar to cell spreading,
zyxin expression directly correlates with the cell growth rate.
Zyxin-containing focal adhesions are more prominent in
melanoma cells compared to differentiated melanocytes In
order to determine the relationship of zyxin expression to cell
spreading, we investigated the distribution of zyxin in melanocytes
and melanoma cells using double ¯uorescent labeling of zyxin and
actin. Confocal pseudo-colorized images were obtained by
assigning zyxin green, actin red, and the green/red overlap as
yellow. In well-spread cells, numerous and prominent zyxin-
labeled focal adhesions were identi®ed. As can be seen in melanoma
cell line 2 shown in Fig 4(A), actin bundles extended along the cell
border or traversed the cell cytoplasm and frequently terminated
near the periphery. Antizyxin antibodies localized to peripheral
oval or elliptical sites consistent with focal adhesion plaques
(Fig 4B). Examination of the overlap image indicated that the actin
component of stress ®bers terminates at the focal adhesion with
zyxin (Fig 4C). Furthermore, the green component extends
beyond the yellow component, indicating that zyxin
concentration is greater than actin in the distal portion of the
focal adhesion. The melanoma cell lines exhibited variable numbers
of zyxin-containing adhesion plaques; however, they were larger
and more numerous compared to melanocytes. In melanocytes,
actin bundles were prominent within cell projections and also as
central stress ®bers (Fig 4D). Focal adhesions containing zyxin
were also identi®ed, but were faint, dot-like, and con®ned to distal
dendritic projections and not associated with central stress ®bers
(Fig 4E, F). Overlap images showed faint yellowish colocalization
of actin and zyxin at distal dendrites (Fig 4F, arrows).
TPA inhibition of melanoma cell proliferation is
accompanied by a decrease in cell spreading, zyxin
expression, and increased differentiated phenotype,
whereas TPA induces zyxin expression in
melanocytes Prolonged TPA treatment depletes PKC and
inhibits melanoma cell growth (Becker et al, 1990; Coppock et
al, 1992; Nishizuka, 1995). We tested whether TPA modulation of
cell growth is accompanied by changes in cell spreading and zyxin
expression. Figure 5(A) shows the effect of increasing
concentrations of TPA on the proliferation of several of the well-
spread melanoma cell lines including lines 1, 2, 3, and 5. A
signi®cant inhibition of cell growth (p < 0.001) was observed at
10±9, 10±8, or 10±7 M TPA. This effect was reversible; removal of
TPA permitted cell growth to return to control rates.
To determine whether TPA inhibition of proliferation is
accompanied by modulation of cell spreading, we studied cell
spreading (projected cell area) as a function of TPA concentration.
Projected cell areas were measured using image analysis on
approximately 60 cells in three different ®elds exposed to TPA
concentrations of 10±9, 10±8, or 10±7 M for 5 d. The effects were
compared to the control dishes. Projected cell area was signi®cantly
reduced (p < 0.001) at 10-8±10-7 M TPA. Data are shown for cell
line 2 in Fig 5(B).
The decrease in proliferation and cell spreading induced by
TPA was associated with an increased differentiated phenotype
of the melanoma cells. The number of bipolar, tripolar, and
dendritic melanoma cells increased in a dose-dependent manner
(Fig 6).
The TPA concentrations that induced a signi®cant reduction in
cell spreading and differentiation corresponded to the reduction in
cell proliferation. To test the hypothesis that zyxin expression is
associated with these changes, immunoblots were performed
following 5 d exposure to 10±11, 10±10, 10±9, 10±8, and 10±7 M
TPA. No signi®cant reduction was detected at 10±11, 10±10, or 10±9
Figure 5. TPA induces growth inhibition of melanoma cells and
decreases melanoma cell spreading. (A)±(D) Melanoma cells (cell
lines 1, 2, 3, and 5 shown) were seeded at low density (5 3 104) and
counted after 1, 3, 5, and 7 d incubation in different concentrations of
TPA. TPA inhibition of growth is noted at 10±9, 10±8, and 10±7 M (cell
lines 3 and 5), 10±8 and 10±7 M (cell line 2), or 10±7 M (cell line 1). (B)
Bar graph showing the projected area of melanoma cells following 5 d
exposure to TPA (cell line 2 shown). Standard deviation was determined
from triplicate ®elds. TPA at 10±8 and 10±7 M signi®cantly reduced
projected cell area (*p < 0.001).
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M TPA in all melanoma cell lines (Fig 7A, cell line 2 shown).
Zyxin expression decreased at 10±8±10±7 M TPA in all cell lines
tested, however, corresponding to the decrease in cell spreading
and cell proliferation. Regression analysis of zyxin expression in
several scanned blots to cell spreading and to proliferation
con®rmed these relationships (p < 0.05). In contrast to melanoma
cells, zyxin expression in normal melanocytes signi®cantly increased
at 10±8 and 10±7 M TPA (Fig 7B).
To investigate whether the decrease in zyxin expression and cell
area was associated with a change in the distribution of zyxin,
melanoma cells were cultured in the presence of 10±7 M TPA and
double ¯uorescent labeling for zyxin and actin was performed.
Phase contrast microscopy con®rmed that the shape of the cells
changed from large polygonal cells to smaller polygonal cells with
numerous bipolar cells and occasional tripolar and dendritic cells
that resembled the melanocyte phenotype (compare Fig 6D and
Fig 2A). Confocal microscopy revealed that the actin-labeled stress
®bers were not well developed (Fig 8A) and that zyxin focal
adhesions were signi®cantly smaller than controls (compare
Fig 8B, arrows, and Fig 4B). The size of the overlap of actin and
zyxin was also reduced compared to controls (compare Fig 8C
with Fig 4C) and resembled the melanocyte phenotypic distribu-
tion of actin and zyxin.
In order to test whether the increase in zyxin expression in
normal human melanocytes is accompanied by a detectable change
in cell spreading, zyxin-staining focal adhesions, and actin distri-
bution, melanocyte cultures were exposed to 10±7 M TPA for 7 d
and then double labeled for actin and zyxin. The response of
normal human melanocytes to TPA was opposite to that observed
in the melanoma cells. TPA induced more actin-staining bundles
(compare Fig 8D with Fig 4D) and increased the number and size
of the zyxin-stained focal adhesions (compare Fig 8E with Fig 4E)
compared to diluent-treated melanocytes. Larger zyxin and actin
bundle overlap regions in the distal dendrites were also seen in the
TPA-treated melanocytes compared to controls (compare Fig 8F
with Fig 4F). Projected cell area increased in conjunction with
increased zyxin-stained focal adhesions. Interestingly, an increase in
dendrite formation was also observed associated with zyxin focal
adhesions in treated melanocytes.
DISCUSSION
Cell spreading or ``stretching'' is important for cell survival in cell
types that are substrate dependent (Ruoslahti, 1997). Chen et al
(1997) developed a method in which they could increase the
projected cell area of endothelial cells while maintaining the area of
focal adhesion to the ECM substrate constant. They found that the
proliferation rate in the spread or ``stretched'' cells was higher than
the rate in those less spread. DNA synthesis and growth increased
Figure 6. TPA treatment of melanoma cells
promotes a differentiated phenotype. Phase
contrast photomicrographs showing that increasing
concentrations of TPA from 10±11 M (A) to
10±9 M (B), 10±8 M (C), or 10±7 M (D) promote
a bipolar or tripolar phenotype with focal
dendritic formation after 5 d exposure. Scale bar:
100 mm.
Figure 7. TPA treatment in a dose-dependent manner decreases
zyxin expression in melanoma cells and conversely increases
zyxin expression in melanocytes. (A) 30 mg of total protein of
melanoma cells (cell line 2 shown) were loaded onto each lane on the
gel from each dish treated for 5 d with TPA concentrations from left to
right as follows: 10±11 M, 10±10 M, 10±9 M, 10±8 M, and 10±7 M (top
panel). Bottom panel shows amido black stained lower third of the
nitrocellulose membrane. (B) In contrast, Western immunoblot detection
of zyxin in similarly treated melanocytes reveals an increase in response
to TPA treatment.
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with more spreading of the cell, whereas apoptosis decreased. These
®ndings elegantly demonstrate the importance of cell geometry on
growth and survival. The genotypic changes in malignancy that
alter the signal transduction pathways in regulating normal growth
may also modify the normal cytoskeletal±ECM interactions.
Likewise, genotypic changes altering cytoskeletal±ECM inter-
actions may provide feedback signals for continued growth.
The focal adhesion is an intensively investigated macromolecular
complex involved in the formation of cytoskeletal±ECM and cell±
cell contacts (Burridge and Chrzanowska-Wodnicka, 1996). The
major components of the focal adhesion include the ECM
molecule ®bronectin, the transmembrane integrin dimers a5b1
and avb3, and three major structural proteins believed to directly
link or stabilize clustered integrins to actin ®lament bundles: a-
actinin, talin, and vinculin (Burridge and Chrzanowska-Wodnicka,
1996). Some of the latter proteins can be phosphorylated and are
thus candidates as regulatory proteins. A large number of other
proteins that localize to focal adhesions are implicated as regulatory
proteins or signal transduction proteins, however, including PKC,
paxillin, FAK, and the focus of this investigation, zyxin.
Zyxin localizes to focal contacts, circumferential actin ®lament
bundles of adherens junctions, and along the distal termination
region of stress ®bers (Beckerle, 1986; Crawford and Beckerle,
1991). It is present at substoichiometric levels compared to a-
actinin, talin, and vinculin (Crawford et al, 1992). In addition,
zyxin is phosphorylated on multiple sites in vivo. The latter ®ndings
implicate a possible regulatory role for zyxin at focal adhesions.
Even more intriguing, zyxin displays three cysteine- and histidine-
rich motifs called LIM domains. LIM domains are conserved
regions and are found in a number of proteins involved in the
regulation of cell proliferation and differentiation (Sadler et al, 1992;
Schmeichel and Beckerle, 1994; Macalma et al, 1996). Zyxin is
associated with the cytoskeleton, whereas most LIM domain
expressing proteins are present in the nucleus (Freyd et al, 1990;
Liebhaber et al, 1990; McGuire et al, 1991). LIM domains act as
modular adapters that mediate protein±protein interactions in signal
cascade mechanisms, in transcription factors, or as structural
molecular scaffolding (Sadler et al, 1992; Crawford et al, 1994;
Schmeichel and Beckerle, 1994). It is postulated that in combin-
ation with its low abundance and the general function of LIM
domains, zyxin could be a signaling protein shuttling between the
cytoskeleton and the nucleus that regulates cell growth and/or
differentiation (Sadler et al, 1992; Macalma et al, 1996; Nix and
Beckerle, 1997). In addition, zyxin shares a domain with Listeria
ActA and functions similarly in its ability to stimulate actin ®lament
assembly (Golsteyn et al, 1997). Finally, direct evidence shows
zyxin plays an important role in the spatial control of actin ®lament
assembly (Beckerle, 1997).
Cell transformation often brings about a marked difference in
focal adhesion formation, actin distribution, and cell motility. In
order to investigate whether zyxin plays a role in melanocyte and
melanoma cell spreading and proliferation, we characterized zyxin
expression and its modulation by phorbol esters in relation to
projected cell area and growth in primary melanocyte cultures and
six established melanoma cell lines. The six melanoma cell lines
differ widely in cell adhesion, motility, and metastatic behavior as
shown in previous reports (Byers et al, 1991, 1993; Etoh et al, 1993;
Vink et al, 1993; Akasaka et al, 1995). These lines differ in their
a5b1 integrin (Dekker et al, 1994) and FAK (Akasaka et al, 1995)
expression, both important components of the adhesion plaques.
The presence of a5b1, avb3, or avb5 integrin and increased
phosphorylated FAK correlates with formation of stress ®bers and
cell migration rates in these melanoma cell lines (Byers et al, 1991;
van Leeuwen et al, 1994; Akasaka et al, 1995).
In this study, we found increased expression of zyxin, FAK, and
paxillin in melanoma cells compared to melanocytes. These
®ndings suggest that there is a concerted upregulation of focal
adhesion machinery in melanoma cells. This is supported by the
®nding that melanocytes exhibit delicate actin ®lament bundles
with small focal adhesions in the periphery of the dendrites whereas
the melanoma cell lines exhibited larger actin bundles converging
on larger, more numerous zyxin-staining plaques. Our data also
suggest that divergence in expression of zyxin, FAK, and paxillin,
however, may indicate functional differences among the cell lines.
For example, a 2±5-fold increase in zyxin and FAK correlated with
a 2±6-fold increase in projected cell area (p < 0.05) whereas paxillin
did not correlate with projected cell area. These ®ndings support
the hypothesis that zyxin and FAK promote focal adhesion
formation and thus alter cell stretching, growth, and survival.
The association of large actin ®lament bundles with large zyxin-
containing focal adhesions is also consistent with a mechanism in
which zyxin plays a role in the spatial control of actin ®lament
assembly (Beckerle, 1997).
Our data also supported a divergence of function of the focal
adhesion proteins in regulating cell proliferation. We determined
that zyxin but not FAK or paxillin expression correlate with cell
proliferation rates. Neonatal melanocyte doubling time is twice that
of the slowest growing melanoma cell lines and zyxin expression in
melanocytes was at least half the level in all melanoma cell lines
tested. In order to further investigate the relationship of zyxin
Figure 8. TPA decreases zyxin-stained focal
adhesions and bundles of actin ®laments in
melanoma cells and conversely increases
zyxin-stained focal adhesions and actin
bundles in melanocytes. (A)±(C) Melanoma
cells (cell line 2) were plated at low density and
cultured for 5 d in the presence or absence of
10±7 M TPA. TPA-treated cells show bipolar
phenotype with poorly de®ned (A) actin-stained
stress ®bers and (B)decreased focal distal staining
for zyxin (arrows, compare with Fig 4B). (C)
Small focal adhesions with actin and zyxin overlap
are identi®ed at the distal ends of the bipolar cells.
(D)±(F) Normal human melanocytes were plated
at low density in the presence of 10±7 M TPA.
(D) TPA-treated melanocyte demonstrates more
actin bundles than untreated melanocyte (compare
with Fig 4D). (E) TPA induced prominent
formation of zyxin-stained focal adhesions (arrows),
increased cell spreading, and dendrite formation
(compare with Fig 4E). (F) Overlap pseudo
yellow color of zyxin and actin double labeling
(compare with Fig 4F). Scale bar: 20 mm.
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expression and cell growth we tested a compound that could
potentially modulate zyxin expression. We found that TPA
reduced cell proliferation rates and decreased zyxin expression on
all six melanoma cell lines in a dose-dependent manner. In contrast,
TPA is a well-known mitogen of normal melanocytes and we
found that it increased zyxin expression in cultured normal
melanocytes.
We chose TPA to test modulation of zyxin expression in
melanoma cells and melanocytes. This phorbol ester is known to
dramatically affect cell shape and cell growth in a variety of cell
types as well as exhibit a differential effect in melanocytes and
melanoma cells (Halaban et al, 1986; Arita et al, 1992, 1994; Brooks
et al, 1992). Likewise, TPA treatment empirically reduces mela-
noma metastatic potential in animal models (Bennett et al, 1994).
Several theories of the underlying basic mechanisms of these
complex processes are under investigation. The cell shape changes
accompanying phorbol ester are believed to be mediated in part by
its binding to PKC. PKC responds to phorbol ester in two ways:
one is a short-term effect with direct binding and activation within
minutes (Nishizuka, 1995), and the other effect is a long-term one
associated with marked depletion of PKC after a few days (Young
et al, 1987; Nishizuka, 1995). The short-term effect is exempli®ed
by rapid melanoma cell spreading induced by TPA after 30 min and
can be blocked by inhibitors of PKC (van Leeuwen et al, 1994). On
the other hand, depletion of PKC with long-term treatment
(several days) with 10±8 and 10±7 M TPA led to a signi®cant
downregulation of zyxin that was associated with a decrease in cell
spreading. Furthermore, the dosages of TPA that elicited a loss in
projected cell area were the same concentrations at which cell
proliferation of melanoma cells was inhibited. Confocal images
con®rmed that the shape changes were associated with decreased
zyxin localization into focal adhesions. These ®ndings are consistent
with the role of PKC-mediated pathways and zyxin in the
regulation and spatial organization of actin ®laments (Burridge and
Chrzanowska-Wodnicka, 1996; Beckerle, 1997; Golsteyn et al,
1997).
The exact mechanisms of PKC interplay with zyxin in the
control of focal adhesions, actin ®lament assembly, and cell shape
changes are not fully understood. Early reports indicating that PKC
may play a functional role in regulating focal adhesions were based
on evidence that PKC is preferentially localized at focal adhesions
(Jaken et al, 1989). More recently it was found that PKC plays a role
in the phosphorylation of FAK (Lewis et al, 1996). Finally, the role
of PKC is not restricted to proteins at the focal adhesions as it is also
found along the actin- and myosin-containing stress ®bers. Indeed,
formation of focal adhesions is dependent on the cytoplasmic
tension imparted by acto-myosin ATPase activity, which induces
the actin ®laments to pull on and cluster integrins, thereby
activating them and promoting the macromolecular assembly for
the focal adhesion (Burridge and Chrzanowska-Wodnicka, 1996).
Zyxin may direct where additional actin ®lament nucleation must
occur in response to greater tension (Beckerle, 1997).
PKC appears to modulate acto-myosin mediated cytoplasmic
tension in at least three ways. First, PKC may indirectly inhibit
myosin phosphatase, by generating arachidonic acid, thus preserv-
ing the activating phosphorylation sites of myosin light chains.
Second, PKC stimulates the phosphorylation of calponin, which
induces the latter to dissociate from actin ®laments and permits
increased myosin and actin interaction. Lastly, PKC phosphorylates
two different phosphorylation sites in the myosin light chain that
are inhibitory, thus decreasing myosin ATPase activity (Burridge
and Chrzanowska-Wodnicka, 1996). In summary, the ®rst and
second pathways act as agonists to contractility whereas the third
pathway is antagonistic to the ®rst two. Depletion of PKC by
prolonged TPA treatment would therefore decrease cytoplasmic
tension in the ®rst and second pathways and increase tension in the
third pathway. We observed a net loss in zyxin-stained focal
adhesions and decrease in stress ®bers, indicating a decrease in
cytoplasmic tension. These ®ndings implicate a greater signi®cance
of the ®rst two PKC-mediated pathways than the third in
melanoma cells. This hypothesis does not account for the relative
contribution of PKC in FAK or integrin activation as mentioned
above, however, nor non-PKC TPA-mediated effects on the cell.
The mechanism of PKC-mediated effects on cell spreading and cell
growth is complex and will require future investigation to de®ne
the relative importance of each pathway.
In summary, we ®nd a 2±5-fold difference in zyxin expression
between cultured melanocytes and melanoma cells. The amount of
expressed zyxin directly correlates with the mean projected cell area
of the melanocytes and melanoma cell lines. Zyxin expression also
related to cell proliferation; melanocyte proliferation rate is half that
of the slowest growing melanoma cell line. Finally, TPA-induced
downregulation of zyxin is associated with decreased cell spreading,
inhibition of cell proliferation, and promotion of a more differen-
tiated bipolar phenotype. Consistent with the opposite effects of
TPA on growth in melanoma cells versus melanocytes, TPA
induced opposite effects on zyxin expression in melanoma cells and
melanocytes. These ®ndings are consistent with the hypothesis that
zyxin plays a role in cell spreading, proliferation, and differenti-
ation.
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